Gene · 2530
Papers1,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FUT8 reprograms glycolytic metabolism to promote PKM2 lactylation and drive clear cell renal cell carcinoma progression. | Cell Death Discov | 2026 | 41857011 | PubTator, text mining | PubMed |
| Galactose tolerance in adults with classical galactosaemia. Considering the gaps. | Mol Genet Metab Rep | 2026 | 41798075 | PubTator, text mining | PubMed |
| Core fucosylation of NCEH1 by FUT8 promotes progression of high-grade serous ovarian cancer by driving tumor-associated macrophage M2 polarization. | Oncogene | 2026 | 41786877 | PubTator, text mining | PubMed |
| Structural determinants of site-specific Core Fucosylation in human transferrin: insights from crystallography and molecular dynamics. | Glycobiology | 2026 | 41757486 | PubTator, text mining | PubMed |
| Hypofucosylation promotes pertussis toxin binding to cell surface glycococonjugates and pertussis toxin-induced intracellular ERK signaling. | Glycobiology | 2026 | 41744063 | PubTator, text mining | PubMed |
| FUT8 Catalysis Involves GDP-Fucose-Induced Loop Activation Promoting a Reaction at the SN1‑SN2 Frontier. | ACS Catal | 2026 | 41743314 | PubTator, text mining | PubMed |
| Glycolysis-related genes for bladder cancer: A Mendelian randomization analysis. | Biochem Biophys Rep | 2026 | 41732417 | PubTator, text mining | PubMed |
| Immunoglobulin G N-glycosylation remodeling in viral infections: immunomodulatory roles and potential biomarker implications. | Front Immunol | 2026 | 41727429 | PubTator, text mining | PubMed |
| TGIF2-mediated HMGB3 overexpression promotes esophageal squamous cell carcinoma proliferation and metastasis through TLR3/TGF-β signaling. | Genes Dis | 2026 | 41716633 | PubTator, text mining | PubMed |
| Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer. | Cell Rep Med | 2026 | 41707651 | PubTator, text mining | PubMed |
| A regulatory circuit operated by KDELR1 and KDELR3 fine-tunes the composition of the early secretory pathway. | Cell Mol Life Sci | 2026 | 41706164 | PubTator, text mining | PubMed |
| GlycoRNAs: Biological functions and novel antiviral targets. | Virol Sin | 2026 | 41698513 | PubTator, text mining | PubMed |
| Exploiting human fucosyltransferase 8 allostery with a covalent inhibitor for core fucosylation suppression. | Nat Commun | 2026 | 41667477 | PubTator, text mining | PubMed |
| Fut8-Mediated Core Fucosylation of Toll-Like Receptor 4 Exacerbates Periodontitis Via Hyperactivation of NF-κB Signalling. | Int Dent J | 2026 | 41653834 | PubTator, text mining | PubMed |
| Signal peptide peptidase- and SPP-like 3-dependent shedding of α1,6-fucosyltransferase differentially affects core fucosylation. | J Biol Chem | 2026 | 41617026 | PubTator, text mining | PubMed |
| Fucosyltransferase 8 facilitates EMT in glioblastoma cells through the remodelling of TGF-β receptor core fucosylation. | Open Biol | 2026 | 41592739 | PubTator, text mining | PubMed |
| A Chemoenzymatic Method To Systematically Quantify Core Fucosylation Stoichiometry of Glycoproteins and Reveal Its Roles in EMT and Embryonic Development. | Anal Chem | 2026 | 41553297 | PubTator, text mining | PubMed |
| Predictive N‑Glycan Signatures of Severe Traumatic Brain Injury in Biofluids Using LC-MS/MS. | ACS Omega | 2026 | 41552607 | PubTator, text mining | PubMed |
| CRISPR-based precise methylation of specific FUT8 promoter regions allows isolation of CHO cells with a fine-tuned glycoprofile. | J Biotechnol | 2026 | 41506457 | PubTator, text mining | PubMed |
| Core Fucosylation Represses SMURF1-Dependent Degradation of CD47 to Promote Tumor Immune Evasion. | Adv Sci (Weinh) | 2026 | 41355073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2530/papers?page=2